BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...
Despite elegant efforts to design for safe use, rigorous standards and regulatory requirements, and lots of training of ...
The American Hospital Association (AHA) and the Association for Advancement of Medical Instrumentation (AAMI) brought together a small group composed of hospital and health system leaders, device ...
This 17-Year-Old Scientist Is Making an Acetaminophen Alternative That Is Less Damaging to the Liver
Chloe Yehwon Lee’s research could change the painkiller, known by the brand name Tylenol, for the better, ultimately reducing ...
At JP Morgan 2025, pharmaphorum editor-in-chief Jonah Comstock sat down with Dr Michael Bauer, CEO of Quantro Therapeutics, about his company’s novel approach to gene transcription factor control.
The field is evolving—don’t get left behind. Expand your network and join 80+ structural biologists, medicinal chemists, ...
Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...
The global Drug Discovery Services Market , valued at US$14.89 billion in 2024, is forecasted to grow at a robust CAGR of 10.7%, reaching US$16.36 ...
3d
The global Drug Discovery Services Market , valued at US$14.89 billion in 2024, is forecasted to grow at a robust CAGR of ...
South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to ...
The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback